Search Results - "CANDEL, M. T"

Doxorubicin in combination with fluorouracil and cyclophosphamide (i.v. FAC regimen, day 1, 21) versus methotrexate in combination with fluorouracil and cyclophosphamide (i.v. CMF regimen, day 1, 21) as adjuvant chemotherapy for operable breast cancer: a study by the GEICAM group by Martin, M., Villar, A., Sole-Calvo, A., Gonzalez, R., Massuti, B., Lizon, J., Camps, C., Carrato, A., Casado, A., Candel, M. T., Albanell, J., Aranda, J., Munarriz, B., Campbell, J., Diaz-Rubio, E.

“…Background: The purpose of this study was to determine the relative efficacy of doxorubicin versus methotrexate in combination with intravenous…”
Get full text

A randomized phase II trial of 5-fluorouracil, with or without human interferon-β, for advanced colorectal cancer by VILLAR-GRIMALT, A, CANDEL, M. T, MASSUTI, B, LIZON, J, SANCHEZ, B, FRAU, A, GOROSTIDI, B, GOEDKOOP, R

“…This study compared the efficacy and safety of 5-fluorouracil (5-FU) monotherapy to that of 5-FU combined with natural human interferon-beta (IFN-beta) in…”
Get full text

120-hour 5-fluorouracil (5-FU) continuous infusion (CI) plus BCNU in advanced colorectal cancer by Villar-Grimalt, A, Candel, M T, Delgado, F, García-Reinoso, J, Sanchis, C, Viciano, V, Asencio, F, Martínez-Abad, M, Aguilo, J, Sánchez, J J

“…Seventy-five previously untreated patients with measurable advanced colorectal cancer were treated with 5 fluorouracil 1,000 mg/m2 as a 24-hour intravenous…”
Get more information

Combination of etoposide, adriamycin and cisplatin (EAP) in gastric cancer: association with severe toxicity by Villar-Grimalt, A, Candel, M T, Garcia, J, Bernacer, B, Jimeno, J

Get more information

Carcinoma of unknown origin by Villar, A, Candel, M T, García-Reinoso, J

Get more information

Combination of etoposide, adriamycin and cisplatin (EAP) in gastric cancer: association with severe toxicity by Haim, N, Robinson, E

Get more information

Phase II study with iododoxorubicin in measurable advanced colorectal adenocarcinoma. Effective rescue using weekly high-dose 5-fluorouracil (WFU). Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD), Work Group of SEOM (Spanish Medical Oncology Society) by Villar-Grimalt, A, Aranda, E, Massutí, B, Belón, J, Antón, A, Jimeno, J M, Candel, M T, García de Paredes, M L, Colajori, E

“…To evaluate a new anthracycline 4'-iodo-4'-deoxydoxorubicin (I-DOX) in patients with measurable advanced colorectal adenocarcinoma in a phase II study. We…”
Get more information

Size of breast cancer at the time of initial diagnosis by Villar, A, Candel, M T, Delgado, F, García, J, Melchor, I, García, A, Aguiló, J, Asencio, F, Viciano, V, González, I

“…To observe whether patients with breast cancer of an epithelial strain consult physician with a less advanced disease, the patients attended by the Valencian…”
Get more information